SIMILAR PATTERNS OF AMINO ACIDS FOR 1ISM_A_NCAA303_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ism | BONE MARROW STROMALCELL ANTIGEN 1 (Homo sapiens) |
PF02267(Rib_hydrolayse) | 9 | TRP A 77HIS A 81LEU A 97SER A 98ASP A 107TRP A 140SER A 144PHE A 173GLU A 178 | NCA A 303 (-4.4A)NCA A 303 (-4.1A)NCA A 303 (-4.3A)NCA A 303 (-3.9A)NCA A 303 (-4.4A)NCA A 303 (-4.0A)NCA A 303 ( 3.7A)NCA A 303 (-3.7A)NCA A 303 ( 4.4A) | 0.00A | 1ismA-1ismA:43.0 | 1ismA-1ismA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2eg9 | ADP-RIBOSYL CYCLASE1 (Mus musculus) |
PF02267(Rib_hydrolayse) | 6 | TRP A 129LEU A 149ASP A 159TRP A 193SER A 197GLU A 230 | None | 0.92A | 1ismA-2eg9A:9.1 | 1ismA-2eg9A:32.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rch | CYTOCHROME P450 74A (Arabidopsisthaliana) |
PF00067(p450) | 5 | HIS A 342LEU A 513SER A 512ASP A 496PHE A 489 | None | 1.20A | 1ismA-2rchA:0.0 | 1ismA-2rchA:20.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3gc6 | ECTO-NAD+GLYCOHYDROLASE (CD38MOLECULE) (Bos taurus) |
PF02267(Rib_hydrolayse) | 5 | TRP A 118LEU A 137ASP A 147TRP A 181SER A 185 | None | 0.45A | 1ismA-3gc6A:27.4 | 1ismA-3gc6A:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3i9k | ADP-RIBOSYL CYCLASE (Aplysiacalifornica) |
PF02267(Rib_hydrolayse) | 5 | TRP A 77LEU A 97TRP A 140SER A 144PHE A 174 | None | 0.40A | 1ismA-3i9kA:28.4 | 1ismA-3i9kA:32.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3p5s | CD38 MOLECULE (Bos taurus) |
PF02267(Rib_hydrolayse) | 6 | TRP A 118LEU A 137ASP A 147TRP A 181SER A 185GLU A 218 | AVU A 280 (-3.8A)AVU A 280 (-3.7A)AVU A 280 (-3.9A)AVU A 280 (-3.6A)AVU A 280 (-2.9A)AVU A 280 (-2.4A) | 0.44A | 1ismA-3p5sA:27.3 | 1ismA-3p5sA:33.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3rom | ADP-RIBOSYL CYCLASE1 (Homo sapiens) |
PF02267(Rib_hydrolayse) | 6 | TRP A 125LEU A 145ASP A 155TRP A 189SER A 193GLU A 226 | 48Z A 301 (-3.6A)48Z A 301 ( 4.8A)NoneNone48Z A 301 (-2.8A)48Z A 301 (-2.0A) | 0.62A | 1ismA-3romA:28.3 | 1ismA-3romA:34.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3up1 | INTERLEUKIN-7RECEPTOR SUBUNITALPHA (Homo sapiens) |
PF00041(fn3) | 5 | HIS A 160ASP A 146TRP A 200SER A 203GLU A 182 | None | 1.27A | 1ismA-3up1A:undetectable | 1ismA-3up1A:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lp4 | ADVANCEDGLYCOSYLATION ENDPRODUCT-SPECIFICRECEPTOR (Homo sapiens) |
PF00047(ig)PF08205(C2-set_2) | 5 | HIS A 158LEU A 155SER A 209SER A 190GLU A 175 | None | 1.38A | 1ismA-4lp4A:0.0 | 1ismA-4lp4A:23.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5bni | UNCHARACTERIZEDPROTEIN (Sus scrofa) |
PF02267(Rib_hydrolayse) | 5 | LEU A 150ASP A 160TRP A 193SER A 197GLU A 230 | None | 0.54A | 1ismA-5bniA:26.5 | 1ismA-5bniA:31.76 |